HARDY REGINALD L 4
4 · Brickell Biotech, Inc. · Filed Jul 2, 2020
Insider Transaction Report
Form 4
HARDY REGINALD L
DirectorChairman of the Board
Transactions
- Tax Payment
Common Stock
2020-06-30$1.00/sh−283$283→ 196,472 total - Exercise/Conversion
Common Stock
2020-06-30+883→ 196,755 total - Exercise/Conversion
Restricted Stock Units
2020-06-30−883→ 1,765 total→ Common Stock (883 underlying)
Holdings
- 17,260(indirect: By Trust)
Common Stock
- 21,826(indirect: By Spouse)
Common Stock
- 266,447(indirect: By Self as General Partner)
Common Stock
- 9,261(indirect: By Spouse)
Common Stock
- 17,260(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]Restricted stock units ("RSUs") converted into common stock on a one-for-one basis.
- [F2]Represents shares withheld to satisfy tax withholding obligations upon the vesting of RSUs.
- [F3]These RSUs were granted on February 14, 2020 and vest in installments through August 31, 2020.
- [F4]The reporting person filed a Form 4 on June 5, 2020 which reported, among other transactions, the vesting on various dates of portions of a grant of RSUs made to the reporting person on February 14, 2020. Column 9 of Table II of that Form 4 incorrectly reported the number of unvested RSUs remaining from that grant following each such vesting. The number reported in this Column 9 of Table II of this Form 4 represents the correct number of unvested RSUs remaining from the February 14, 2020 grant following the vestings that were reported on the Form 4 filed on June 5, 2020, as well as the vesting that occurred on June 30, 2020 as reported on this Form 4.